Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |